NTRB
NTRB
NASDAQ · Pharmaceuticals

Nutriband Inc

$5.52
-0.56 (-9.21%)
As of Nov 7, 2:37 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +525.2% upside
Low Target $26.32
Average Target $34.51
High Target $56.88
Current Price $5.52
Current
$5.52
Target
$34.51
$26.32 $34.51 avg $56.88
Scenario Analysis
Bear Case
$26.32
376.8%
Low target
Base Case
$34.51
+525.2%
Avg target
Bull Case
$56.88
+930.4%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.19
-39.9% from high
52-Week Low
$2.80
+97.1% from low
Target vs 52W High
$34.51
+275.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%